Advertisement

Topics

Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results

11:44 EDT 2 Nov 2018 | Investing News Network

Checkpoint Therapeutics (NASDAQ:CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced financial results and recent corporate highlights for the third quarter ended September 30, 2018. As quoted in the press release: “In the third quarter of 2018, we announced positive … Continued

The post Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results appeared first on Investing News Network.

Original Article: Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results

NEXT ARTICLE

More From BioPortfolio on "Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...